Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age40+
SponsorMarmara University

About this trial

This study will look at how well a measure called the Qmax/eGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax/eGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.

Eligibility criteria

Qualifiers

Male patients aged 40 years or older presenting with lower urinary tract symptoms (LUTS)

Able to provide informed consent

Willing and able to undergo uroflowmetry and blood testing

Able to complete the IPSS questionnaire, including the QoL item

Disqualifiers

History of urological surgery (e.g., prostatectomy, bladder surgery)

Diagnosed or suspected prostate cancer

Active urinary tract infection (based on clinical symptoms or urinalysis)

Neurological conditions affecting bladder function (e.g., Parkinson's disease, spinal cord injury)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators